Observations placeholder
Sumatriptan and Imitrex
Identifier
017357
Type of Spiritual Experience
Background
eHealthme keeps the figures separate for each trade name
A description of the experience
Sumatriptan is a medication used for the treatment of migraine headaches.
It is a synthetic drug belonging to the triptan class. Structurally, it is an analog of the naturally occurring neuro-active alkaloids dimethyltryptamine (DMT), bufotenine, and 5-methoxy-dimethyltryptamine, with an N-methyl sulfonamidomethyl- group at position C-5 on the indole ring.
Sumatriptan is produced and marketed by various drug manufacturers with many different trade names such as Imitrex, Imigran, and Treximet as a combination product with naproxen.
Sumatriptan is structurally similar to serotonin (5HT), and is a 5-HT receptor (types 5-HT1D and 5-HT1B agonist.
The specific receptor subtype it activates is present in the cranial and basilar arteries. Activation of these receptors causes vasoconstriction of those dilated arteries. Sumatriptan is also shown to decrease the activity of the trigeminal nerve, which, it is presumed [sic], accounts for sumatriptan's efficacy in treating cluster headaches.
On Dec, 29, 2016 4,859 people reported to have side effects when taking Sumatriptan. Among them, 25 people (0.51%) have Hallucination
On Aug, 9, 2015: 5,201 people reported to have side effects when taking Imitrex. Among them, 23 people (0.44%) have Hallucinations.